Travere Therapeutics to Report Second Quarter 2025 Financial Results
Go back to Travere Therapeutics to Report Second Quarter 2025 Financial Results| (NASDAQ: TVTX) | Delayed: 67.23 +1.52 (2.31%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $65.71 | 52 Week High | $ | |||
| Open | $66.37 | 52 Week Low | $ | |||
| Day High | $67.82 | P/E | N/A | |||
| Day Low | $65.76 | EPS | $ | |||
| Volume | 1,085,748 | |||||

